Supplementary Table 3. Genes of Study
Gene Symbol
CXCR4
Name of Gene
Chemokine receptor-4
Function/Role
Reference
uPAR
Urokinase plasminogen
activator receptor
cMET
Cell motility factor
receptor
AMFR
Autocrine motility factor
receptor
11-13
LOX
Lysyl oxidase
14, 15
Fas
Tumour necrosis factor
Receptor
VEGFC
Vascular endothelial
growth factor-C
1-3
4-7
Intra/Extravasation
Anti-Apoptotic
8-10
16, 17
18-21
Angiogenic factors
IL8
Interleukin -8
22-24
Hdm2
Transformed 3T3 double
minute 2
25, 26
OPN
Osteopontin
CA-9
Carbonic anhyrdase IX
Survival/Growth
factors
27-30
Biomarker for
hypoxia
31-33
Supplementary References
1.
Shim H, Lau SK, Devi S, et al. Lower expression of CXCR4 in lymph node
metastases than in primary breast cancers: potential regulation by liganddependent degradation and HIF-1alpha. Biochem Biophys Res Commun
2006;346:252-258.
2.
Darash-Yahana M, Pikarsky E, Abramovitch R, et al. Role of high expression
levels of CXCR4 in tumor growth, vascularization, and metastasis. Faseb J
2004;18:1240-1242.
3.
Dewan MZ, Ahmed S, Iwasaki Y, et al. Stromal cell-derived factor-1 and CXCR4
receptor interaction in tumor growth and metastasis of breast cancer. Biomed
Pharmacother 2006;60:273-276.
4.
Graham CH, Forsdike J, Fitzgerald CJ, et al. Hypoxia-mediated stimulation of
carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int
J Cancer 1999;80:617-623.
5.
Memarzadeh S, Kozak KR, Chang L, et al. Urokinase plasminogen activator
receptor: Prognostic biomarker for endometrial cancer. Proc Natl Acad Sci U S A
2002;99:10647-10652.
6.
Maity A, Solomon D. Both increased stability and transcription contribute to the
induction of the urokinase plasminogen activator receptor (uPAR) message by
hypoxia. Exp Cell Res 2000;255:250-257.
7.
Yoon SY, Lee YJ, Seo JH, et al. uPAR expression under hypoxic conditions
depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast
carcinoma cell line. Cell Res 2006;16:75-81.
8.
Baykal C, Ayhan A, Al A, et al. Overexpression of the c-Met/HGF receptor and
its prognostic significance in uterine cervix carcinomas. Gynecol Oncol
2003;88:123-129.
9.
Ayhan A, Ertunc D, Tok EC, et al. Expression of the c-Met in advanced epithelial
ovarian cancer and its prognostic significance. Int J Gynecol Cancer 2005;15:618623.
10.
Pennacchietti S, Michieli P, Galluzzo M, et al. Hypoxia promotes invasive growth
by transcriptional activation of the met protooncogene. Cancer Cell 2003;3:347361.
11.
Niizeki H, Kobayashi M, Horiuchi I, et al. Hypoxia enhances the expression of
autocrine motility factor and the motility of human pancreatic cancer cells. Br J
Cancer 2002;86:1914-1919.
12.
Funasaka T, Yanagawa T, Hogan V, et al. Regulation of phosphoglucose
isomerase/autocrine motility factor expression by hypoxia. Faseb J 2005;19:14221430.
13.
Tsutsumi S, Yanagawa T, Shimura T, et al. Autocrine motility factor signaling
enhances pancreatic cancer metastasis. Clin Cancer Res 2004;10:7775-7784.
14.
Erler JT, Bennewith KL, Nicolau M, et al. Lysyl oxidase is essential for hypoxiainduced metastasis. Nature 2006;440:1222-1226.
15.
Erler JT, Giaccia AJ. Lysyl oxidase mediates hypoxic control of metastasis.
Cancer Res 2006;66:10238-10241.
16.
Houston A, O'Connell J. The Fas signalling pathway and its role in the
pathogenesis of cancer. Curr Opin Pharmacol 2004;4:321-326.
17.
Das H, Koizumi T, Sugimoto T, et al. Quantitation of Fas and Fas ligand gene
expression in human ovarian, cervical and endometrial carcinomas using real-time
quantitative RT-PCR. Br J Cancer 2000;82:1682-1688.
18.
Ueda M, Hung YC, Terai Y, et al. Vascular endothelial growth factor-C
expression and invasive phenotype in ovarian carcinomas. Clin Cancer Res
2005;11:3225-3232.
19.
Van Trappen PO, Steele D, Lowe DG, et al. Expression of vascular endothelial
growth factor (VEGF)-C and VEGF-D, and their receptor VEGFR-3, during
different stages of cervical carcinogenesis. J Pathol 2003;201:544-554.
20.
Fujimoto J, Toyoki H, Sato E, et al. Clinical implication of expression of vascular
endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers.
Br J Cancer 2004;91:466-469.
21.
Schoppmann SF, Fenzl A, Schindl M, et al. Hypoxia inducible factor-1alpha
correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
Breast Cancer Res Treat 2006;99:135-141.
22.
Kim KS, Rajagopal V, Gonsalves C, et al. A novel role of hypoxia-inducible
factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in
human endothelial cells. J Immunol 2006;177:7211-7224.
23.
Rofstad EK, Halsor EF. Hypoxia-associated spontaneous pulmonary metastasis in
human melanoma xenografts: involvement of microvascular hot spots induced in
hypoxic foci by interleukin 8. Br J Cancer 2002;86:301-308.
24.
Kassim SK, El-Salahy EM, Fayed ST, et al. Vascular endothelial growth factor
and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer
patients. Clin Biochem 2004;37:363-369.
25.
Zhang L, Hill RP. Hypoxia enhances metastatic efficiency by up-regulating
Mdm2 in KHT cells and increasing resistance to apoptosis. Cancer Res
2004;64:4180-4189.
26.
Bardos JI, Chau NM, Ashcroft M. Growth factor-mediated induction of HDM2
positively regulates hypoxia-inducible factor 1alpha expression. Mol Cell Biol
2004;24:2905-2914.
27.
Furger KA, Menon RK, Tuck AB, et al. The functional and clinical roles of
osteopontin in cancer and metastasis. Curr Mol Med 2001;1:621-632.
28.
Said HM, Katzer A, Flentje M, et al. Response of the plasma hypoxia marker
osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol
2005;76:200-205.
29.
Wong YF, Cheung TH, Tsao GS, et al. Genome-wide gene expression profiling
of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J
Cancer 2006;118:2461-2469.
30.
Lukacova S, Khalil AA, Overgaard J, et al. Relationship between radiobiological
hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse
serum. Int J Radiat Biol 2005;81:937-944.
31.
Olive PL, Aquino-Parsons C, MacPhail SH, et al. Carbonic anhydrase 9 as an
endogenous marker for hypoxic cells in cervical cancer. Cancer Res
2001;61:8924-8929.
32.
Kim JY, Shin HJ, Kim TH, et al. Tumor-associated carbonic anhydrases are
linked to metastases in primary cervical cancer. J Cancer Res Clin Oncol
2006;132:302-308.
33.
Vordermark D, Kaffer A, Riedl S, et al. Characterization of carbonic anhydrase
IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor
cells. Int J Radiat Oncol Biol Phys 2005;61:1197-1207.